The value-based cancer care enabler Thyme Care has appointed a scientific advisory board with palliative care expertise to ensure that care and services are aligned with the most up-to-date literature and research.
The four-person board includes experts in palliative care, geriatric oncology, health policy, care delivery, predictive analytics and health care innovation from health systems, cancer centers, and research institutions. The panel will collaborate with Thyme Care’s executive, clinical and operations teams to fine-tune the organization’s care model and support development of new technologies.
The board will also evaluate patient outcomes against evidence-based interventions, as well as contribute to research studies.